Elsevier

Clinical Immunology

Volume 100, Issue 2, August 2001, Pages 181-190
Clinical Immunology

Regular Article
Long-Term Low-Dose IL-2 Enhances Immune Function in Common Variable Immunodeficiency

https://doi.org/10.1006/clim.2001.5052Get rights and content

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by hypogammaglobulinemia and lack of antibody production. Numerous T cell defects have been described, including reduced gene expression and production of IL-2. Since some of the T cell defects could be explained by lack of IL-2, we have been investigating the effects of in vivo IL-2 treatment. Here, a long-acting form of IL-2, PEG-IL-2, was given for 12–18 months to 15 randomly chosen CVID subjects, in comparison to 39 CVID subjects who served as controls. After 6 to 12 months of treatment, T cell proliferative responses to mitogens and to IL-2 were significantly enhanced; proliferative responses to tetanus and candida antigens increased up to 50-fold. Four of eight subjects immunized with the neoantigen bacteriophage φX 174 displayed increased antibody responses after treatment. Treated subjects recorded reduced, but not overall statistically significant, days of bronchitis, diarrhea, and joint pain. These data indicate that IL-2 might serve as an adjuvant to therapy in some subjects with CVID, enhancing T cell functions and reversing T cell anergy in most.

References (48)

  • F. Pandolfi et al.

    Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART

    Clin. Immunol.

    (2000)
  • Clin. Exp. Immunol.

    (1997)
  • M.C. Sneller

    Clinical spectrum of common variable immunodeficiency

    Ann. Intern. Med.

    (1993)
  • R.A. Hermaszewski et al.

    Primary hypogammaglobulinemia: A survey of clinical manifestations and complications

    Q. J. Med.

    (1993)
  • C.A. Janeway et al.

    Agammaglobulinemia

    Trans. Assoc. Am. Phys.

    (1953)
  • O. Saiki et al.

    Three distinct stages of B-cell defect in common varied immunodeficiency

    Proc. Natl. Acad. Sci. USA

    (1982)
  • E.L. Reinherz et al.

    Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders

    J. Clin. Invest.

    (1981)
  • S. Cunningham-Rundles et al.

    Impaired proliferative response to B lymphocyte activators in common variable immunodeficiency

    J. Clin. Immunol.

    (1981)
  • W. Stohl et al.

    In vitro induction of T cell dependent B cell differentiation in patients with common varied immunodeficiency

    Clin. Immunol. Immunopathol.

    (1987)
  • M. Di Renzo et al.

    Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): Role of defective CD28 co-stimulation

    Clin. Exp. Immunol.

    (2000)
  • A.J. Stagg et al.

    Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID)

    Clin. Exp. Immunol.

    (1994)
  • I. Kondratenko et al.

    Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells

    Clin. Exp. Imunol.

    (1997)
  • S.J. Richards et al.

    Abnormal CD45R expression in patients with common variable immunodeficiency and X-linked agammaglobulinemia

    Br. J. Haematol.

    (1992)
  • Cited by (54)

    • Antibody forming cells and plasmablasts in peripheral blood in CVID patients after vaccination

      2011, Vaccine
      Citation Excerpt :

      The other group investigated the specific IgG production ability in CVID patients under immunoglobulin substitution therapy after vaccination against tick-borne encephalitis virus [32]. Immunization with a protein neoantigen, e.g. bacteriophage, and investigation of immune response with neutralization assay brought similar results [39,40]. Nevertheless, there is very little quantitative data correlating individual vaccination responses to proposed classifications of CVID [29,39,41].

    • Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease

      2009, Clinical Immunology
      Citation Excerpt :

      However, since CVID is a polygenic disease and since T cells are important to B cell development and function, we focused on T cell phenotyping. In addition, other laboratories have found that multiple T cell abnormalities ranging from loss of CD4+ naïve cells, disrupted T cell receptor B variable repertoires, to altered cytokine production existing in CVID subjects [3,18–20]. Therefore, we designed our studies to test whether a specific subtype of T cells, the regulatory T cell, was impaired in CVID patients with autoimmune disease.

    View all citing articles on Scopus
    1

    To whom correspondence and reprint requests should be addressed at 1425 Madison Avenue, Mount Sinai School of Medicine, New York 10029. Fax: 212 987 5593. E-mail: [email protected].

    View full text